Domiziana Masci

Università Cattolica del Sacro Cuore

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (4)

Anna Percio

Università Cattolica del Sacro Cuore

ITALY

View details

Usama Ammar

Lecturer of Drug Discovery and Pharmaceutical Science

Edinburgh Napier University

UNITED KINGDOM

View details

Paola Roncada

Full professor

Università degli Studi Magna Graecia di Catanzaro Dipartimento di Scienze della Salute

ITALY

View details

adriano mollica

Professore Ordinario

University of Chieti-Pescara

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Domiziana Masci

Research Interests

Explore related searches

Contact this professor

Articles (10)

One Health Approach in the Era of Emerging Viruses: The Challenge of Usutu Virus

Ferroptosis Induction by a New Pyrrole Derivative in Triple Negative Breast Cancer and Colorectal Cancer

Microwave-assisted synthesis of tubulin assembly inhibitors as anticancer agents by aryl ring reversal and conjunctive approach

Valorization of grape pomace extracts against cranberry, elderberry, rose hip berry, goji berry and raisin extracts: Phytochemical profile and in vitro biological activity

Discovery of Benzopyrone-Based Candidates as Potential Antimicrobial and Photochemotherapeutic Agents through Inhibition of DNA Gyrase Enzyme B: Design, Synthesis, In Vitro and In Silico Evaluation

Lycopene enriched extra virgin olive oil: Biological activities and assessment of security profile on cells

Targeting CBP and p300: Emerging Anticancer Agents

Oxidative Cysteine Post Translational Modifications Drive the Redox Code Underlying Neurodegeneration and Amyotrophic Lateral Sclerosis

Development of N-(4-(1H-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability

Liposome-siderophore conjugates loaded with moxifloxacin serve as a model for drug delivery against Mycobacterium tuberculosis

Collaborators (4)

Anna Percio

Usama Ammar

Paola Roncada

adriano mollica

Make your next move.